133 related articles for article (PubMed ID: 28263728)
1. Is There a Role for Craniofacial Surgery in the Treatment of Extensive or Recurrent Head and Neck Tumors Involving the Cranial Base?
Ma C; Li J; Shen Y; Wu Y; Shi R; Sun J
J Oral Maxillofac Surg; 2017 Sep; 75(9):2006-2019. PubMed ID: 28263728
[TBL] [Abstract][Full Text] [Related]
2. Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study.
Ganly I; Patel SG; Singh B; Kraus DH; Bridger PG; Cantu G; Cheesman A; De Sa G; Donald P; Fliss DM; Gullane P; Janecka I; Kamata SE; Kowalski LP; Levine PA; Medina dos Santos LR; Pradhan S; Schramm V; Snyderman C; Wei WI; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):73-8. PubMed ID: 16415433
[TBL] [Abstract][Full Text] [Related]
3. Craniofacial Resection and Reconstruction in Patients With Recurrent Cancer Involving the Craniomaxillofacial Region.
Chen WL; Yang ZH; Huang ZQ; Fan S; Zhang DM; Wang YY
J Oral Maxillofac Surg; 2017 Mar; 75(3):622-631. PubMed ID: 27717818
[TBL] [Abstract][Full Text] [Related]
4. Free perforator flap transfer for reconstruction of skull base defects after resection of advanced recurrent tumor.
Zhang B; Wan JH; Wan HF; Li DZ; Zhang YX
Microsurgery; 2014 Nov; 34(8):623-8. PubMed ID: 24817431
[TBL] [Abstract][Full Text] [Related]
5. Outcome and complications of extended cranial-base resection requiring microvascular free-tissue transfer.
Clayman GL; DeMonte F; Jaffe DM; Schusterman MA; Weber RS; Miller MJ; Goepfert H
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1253-7. PubMed ID: 7576471
[TBL] [Abstract][Full Text] [Related]
6. Surgical strategy for tumors located in or extending from the intracranial space to the infratemporal fossa-Advantages of the transcranial approach (zygomatic infratemporal fossa approach) and the indications for a combined transcranial and transcervical approach-.
Yoshida K; Kawase T; Tomita T; Ogawa K; Kawana H; Yago K; Asanami S
Neurol Med Chir (Tokyo); 2009 Dec; 49(12):580-6. PubMed ID: 20035132
[TBL] [Abstract][Full Text] [Related]
7. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management.
Raza SM; Ramakrishna R; Weber RS; Kupferman ME; Gidley PW; Hanna EY; DeMonte F
J Neurosurg; 2015 Sep; 123(3):781-8. PubMed ID: 25909577
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of craniofacial and skull base rhabdomyosarcomas.
Yang A; Wickremesekera A; Parker A; Davis C
J Craniofac Surg; 2009 Sep; 20(5):1388-93. PubMed ID: 19816263
[TBL] [Abstract][Full Text] [Related]
9. Cerebral revascularization and carotid artery resection at the skull base for treatment of advanced head and neck malignancies.
Kalani MY; Kalb S; Martirosyan NL; Lettieri SC; Spetzler RF; Porter RW; Feiz-Erfan I
J Neurosurg; 2013 Mar; 118(3):637-42. PubMed ID: 23082880
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of skull base surgery with microvascular reconstruction for malignant disease.
Nouraei SAR; Ismail Y; Gerber CJ; Crawford PJ; McLean NR; Hodgkinson PD
Plast Reconstr Surg; 2006 Oct; 118(5):1151-1158. PubMed ID: 17016183
[TBL] [Abstract][Full Text] [Related]
11. Outcome of resection of infratemporal fossa tumors.
Givi B; Liu J; Bilsky M; Mehrara B; Disa J; Pusic A; Cordeiro P; Shah JP; Kraus DH
Head Neck; 2013 Nov; 35(11):1567-72. PubMed ID: 23322409
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes.
Amit M; Bell D; Hunt PJ; Hanna E; Su SY; Kupferman M; Aashiq M; Takahashi H; Gidley PW; Nader ME; DeMonte F; Raza SM
J Neurosurg; 2020 Jun; 134(5):1392-1398. PubMed ID: 32534492
[TBL] [Abstract][Full Text] [Related]
14. Revision lateral skull base surgery.
Kaylie DM; Wittkopf JE; Coppit G; Warren FM; Netterville JL; Jackson CG
Otol Neurotol; 2006 Feb; 27(2):225-33. PubMed ID: 16436994
[TBL] [Abstract][Full Text] [Related]
15. Recurrent head and neck cancers in the skull base, stereotactic radiosurgery palliation, and risk prognosticators.
Ampil F; Cuellar H; Nathan CA; Smith D; Sin A
Oral Oncol; 2021 Jan; 112():105005. PubMed ID: 33158750
[No Abstract] [Full Text] [Related]
16. Combined craniofacial resection of anterior skull base tumors: long-term results and experience of single institution.
Abuzayed B; Canbaz B; Sanus GZ; Aydin S; Cansiz H
Neurosurg Rev; 2011 Jan; 34(1):101-13. PubMed ID: 20878534
[TBL] [Abstract][Full Text] [Related]
17. Surgical Management of Giant Cell Tumors in Temporomandibular Joint Region Involving Lateral Skull Base: A Multidisciplinary Approach.
Shen Y; Ma C; Wang L; Li J; Wu Y; Sun J
J Oral Maxillofac Surg; 2016 Nov; 74(11):2295-2311. PubMed ID: 27186869
[TBL] [Abstract][Full Text] [Related]
18. A simple classification of cranial-nasal-orbital communicating tumors that facilitate choice of surgical approaches: analysis of a series of 32 cases.
Deng YF; Lei BX; Zheng MG; Zheng YQ; Chen WL; Lan YQ
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2239-48. PubMed ID: 27016919
[TBL] [Abstract][Full Text] [Related]
19. Chondrosarcoma of the skull base: long-term follow-up.
Brackmann DE; Teufert KB
Otol Neurotol; 2006 Oct; 27(7):981-91. PubMed ID: 17006349
[TBL] [Abstract][Full Text] [Related]
20. Reconstructive management of cranial base defects after tumor ablation.
Chang DW; Langstein HN; Gupta A; De Monte F; Do KA; Wang X; Robb G
Plast Reconstr Surg; 2001 May; 107(6):1346-55; discussion 1356-7. PubMed ID: 11335798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
